SEP 9, 2026 · PHASE 1/2 TRIAL
Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
ClinicalTrials.gov
This is a Phase 1/2 trial registration with no results posted; it describes planned enrollment and endpoints only, without efficacy or safety outcomes, making it an early-stage design document rather than evidence of clinical benefit.
Reported
Planned enrollment117
PhasePhase 1/2
Primary outcome (Phase 1)Maximum Tolerated Dose of Cediranib in Comb…